메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
이수경 (연세대학교 의과대학 세브란스병원 약무국) 금민정 (세브란스병원) 고종희 (연세대학교 세브란스병원) 손은선 (세브란스병원) 유윤미 (연세대학교)
저널정보
한국병원약사회 병원약사회지 병원약사회지 제40권 제1호
발행연도
2023.2
수록면
59 - 71 (13page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background : Tumor lysis syndrome (TLS) is a metabolic syndrome caused by the release of intracellular uric acid, potassium, and phosphorus into the blood due to sudden tumor necrosis. If inadequate prophylactic therapy for TLS or treatment is delayed, complication risks may increase. Therefore, it is important to identify patients at high risk of TLS before chemotherapy. In this study, appropriate prophylactic drug use for TLS risk groups was investigated, and its association with TLS occurrence was analyzed. Methods : From January 2019 to December 2021, electronic medical records of adult hematologic oncology patients aged ≥19 years who were hospitalized for their first chemotherapy for hematological tumors were retrospectively analyzed. Diagnosis, hematological and laboratory values, and administration information of allopurinol and rasburicase were collected. TLS risk was evaluated according to the 2010 TLS management recommendation by Cairo et al. Appropriate prophylactic drug use and the TLS occurrence were analyzed. Results : Of 561 patients, 366 (65.2%), 159 (28.3%), and 36 (6.4%) were in low-risk, moderate- risk, and high-risk groups, respectively, by TLS risk classification. A total of 138 (24.6%), 420 (74.9%), and three (0.5%) patients received undertreatment, proper treatment, and overtreatment in TLS prophylaxis, respectively. Multiple logistic regression analysis showed that TLS risk was higher in the high-risk group than in the low-risk group (adjusted OR: 17.14, 95% CI: 5.56-52.87). In terms of the adequacy of TLS prophylaxis, the TLS incidence was the highest in those with under-prophylaxis, although the difference was not statistically significant. Conclusion : Classifying the high-risk group before chemotherapy in hematological malignancies patients is a major predictor of future TLS development. In under-prophylaxis cases, the TLS incidence tended to increase, especially in high-risk groups. Therefore, the decisions of TLS prophylactic drug should be appropriately implemented and monitored before chemotherapy.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0